SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-13-000302
Filing Date
2013-03-08
Accepted
2013-03-07 17:56:26
Documents
2
Period of Report
2013-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CORCEPT THERAPEUTICS 8-K corcept8k.htm 8-K 5977
2 CORCEPT THERAPEUTICS PRESS RELEASE corcepttherapeutics.htm EX-99 17420
  Complete submission text file 0001102624-13-000302.txt   24540
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 13674612
SIC: 2834 Pharmaceutical Preparations